跳至主要内容
临床试验/NCT05056701
NCT05056701招募中不适用

Prediction of Chronic Kidney Disease Following Pre-eclampsia: Diagnosis and Early Care

Centre Hospitalier le Mans2 个研究点 分布在 1 个国家目标入组 400 人开始时间: 2021年8月5日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
400
试验地点
2
主要终点
prevalence of the Chronic Kidney Disease (CKD)

研究概览

简要总结

Pre-eclampsia (PE) is a pregnancy-associated syndrome of variable severity, classically defined by the combination of hypertension and proteinuria in a previously non-hypertensive or proteinuric patient. These symptoms normally resolve within 2-3 months after delivery regardless of the severity of the pre-eclampsia.

Regardless of its definition, preeclampsia is associated with an increased risk of obstetric events and, for the mother, an increased risk of developing chronic kidney disease (CKD), hypertension, diabetes and cardiovascular disease in the broad sense.

The relationship between preeclampsia and Chronic Kidney Disease is, however, complex and not fully understood.

Investigator proposes an interventional study to identify the diagnosis of Chronic Kidney Disease in patients who have developed an episode of Preeclampsia.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Prevention
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Meeting the preeclampsia criteria according to the ISSHP 2018 definitions
  • Having signed the informed consent

排除标准

  • Patient with mental disability or language barrier preventing understanding of the study or consent
  • Person deprived of liberty by judicial or administrative decision
  • Person under forced psychiatric care
  • Person subject to a legal protection measure

结局指标

主要结局

prevalence of the Chronic Kidney Disease (CKD)

时间窗: until 10 years

prevalence of the CKD is measured by the the rate of new CKD Diagnoses (according to the standard definitions)

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验